3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Genitourinary
2
Thoracic
1
Sarcoma
1
Plasma cell
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Wilms Tumor
1
Testicular Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Congenital Abnormalities
1
Interventions
Radiotherapy
144
Doxorubicin
112
Temozolomide
110
Cyclophosphamide
110
Filgrastim
79
Ifosfamide
70
Imatinib Mesylate
69
Etoposide
69
Bevacizumab
55
Vincristine
51
Gemcitabine
50
Peripheral Blood Stem Cell Transplantation
47
Irinotecan
43
Methotrexate
39
Cisplatin
36
Carboplatin
36
Radiation
35
fludarabine phosphate
34
Busulfan
34
pazopanib
32
Sirolimus
30
Melphalan
30
Trabectedin
29
Docetaxel
27
Chemotherapy, Adjuvant
27
Cyclosporine
25
Carmustine
25
sargramostim
24
Surgical Procedures, Operative
23
Sunitinib
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lithium Carbonate
×
Sarcoma
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts